Association of alterations in homologous recombination repair genes with survival and chemotherapy sensitivity in patients with high-grade serous ovarian cancer

被引:0
作者
Khan, Sofia [1 ,2 ]
Nevanlinna, Heli [1 ,2 ]
机构
[1] Univ Helsinki, Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Helsinki, Finland
关键词
D O I
10.1158/1538-7445.AM2012-3107
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3107
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Association of interferon inducible genes with tumor immune microenvironment and chemotherapy resistance in high-grade serous epithelial ovarian cancer
    Au, Katrina K.
    Meunier, Liliane
    Le Page, Cecile
    Graham, Charles H.
    Craig, Andrew W. B.
    Childs, Timothy
    Francis, Julie-Ann
    Squire, Jeremy
    Mes-Masson, Anne-Marie
    Koti, Madhuri
    CANCER RESEARCH, 2016, 76
  • [32] Characteristics of homologous recombination deficiency (HRD) in paired primary and recurrent high-grade serous ovarian cancer (HGSOC).
    Patel, Jai Narendra
    Sehouli, Jahid
    Timms, Kirsten
    Solimeno, Cara
    Reid, Julia E.
    Lanchbury, Jerry S.
    Braicu, Ioana
    Darb-Esfahani, Silvia
    Ganapathi, Mahrukh
    Ganapathi, Ram N.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer
    Nikki L. Burdett
    Madelynne O. Willis
    Kathryn Alsop
    Allison L. Hunt
    Ahwan Pandey
    Phineas T. Hamilton
    Tamara Abulez
    Xuan Liu
    Therese Hoang
    Stuart Craig
    Sian Fereday
    Joy Hendley
    Dale W. Garsed
    Katy Milne
    Shreena Kalaria
    Ashley Marshall
    Brian L. Hood
    Katlin N. Wilson
    Kelly A. Conrads
    Kathleen I. Pishas
    Sumitra Ananda
    Clare L. Scott
    Yoland Antill
    Orla McNally
    Linda Mileshkin
    Anne Hamilton
    George Au-Yeung
    Lisa Devereux
    Heather Thorne
    Andrea Bild
    Nicholas W. Bateman
    G. Larry Maxwell
    Jeffrey T. Chang
    Thomas P. Conrads
    Brad H. Nelson
    David D. L. Bowtell
    Elizabeth L. Christie
    Nature Genetics, 2023, 55 : 437 - 450
  • [34] Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group
    Stiegeler, Nadja
    Garsed, Dale W.
    Au-Yeung, George
    Bowtell, David D. L.
    Heinzelmann-Schwarz, Viola
    Zwimpfer, Tibor A.
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [35] Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer
    Burdett, Nikki L.
    Willis, Madelynne O.
    Alsop, Kathryn
    Hunt, Allison L.
    Pandey, Ahwan
    Hamilton, Phineas T.
    Abulez, Tamara
    Liu, Xuan
    Hoang, Therese
    Craig, Stuart
    Fereday, Sian
    Hendley, Joy
    Garsed, Dale W.
    Milne, Katy
    Kalaria, Shreena
    Marshall, Ashley
    Hood, Brian L.
    Wilson, Katlin N.
    Conrads, Kelly A.
    Pishas, Kathleen, I
    Ananda, Sumitra
    Scott, Clare L.
    Antill, Yoland
    McNally, Orla
    Mileshkin, Linda
    Hamilton, Anne
    Au-Yeung, George
    Devereux, Lisa
    Thorne, Heather
    Bild, Andrea
    Bateman, Nicholas W.
    Maxwell, G. Larry
    Chang, Jeffrey T.
    Conrads, Thomas P. P.
    Nelson, Brad H.
    Bowtell, David D. L.
    Christie, Elizabeth L. L.
    NATURE GENETICS, 2023, 55 (03) : 437 - +
  • [36] Characteristics of homologous recombination deficiency (HRD) in paired primary and recurrent high-grade serous ovarian cancer (HGSOC)
    Patel, J.
    Sehouli, J.
    Timms, K.
    Solimeno, C.
    Reid, J.
    Lanchbury, J.
    Braicu, I.
    Darb-Esfahani, S.
    Ganapathi, M.
    Ganapathi, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [37] Germline and somatic homologous recombination gene mutations in high-grade serous ovarian cancer and clinical outcome.
    Mandilaras, Victoria
    Lheureux, Stephanie
    Stjepanovic, Neda
    Burnier, Julia
    Wilson, Michelle K.
    Wang, Lisa
    Clarke, Blaise
    Shaw, Patricia Ann
    Berman, Hal K.
    Kim, Raymond
    Armel, Susan Randall
    McCuaig, Jeanna
    Volenik, Alexandra
    Ahmed, Lailah
    Misyura, Maksym
    Bedard, Philippe L.
    Siu, Lillian L.
    Kamel-Reid, Suzanne
    Stockley, Tracy
    Oza, Amit M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] Expression of hormone receptors predicts survival and platinum sensitivity of high-grade serous ovarian cancer
    Tan, Jiahong
    Song, Chunyan
    Wang, Daoqi
    Hu, Yigang
    Liu, Dan
    Ma, Ding
    Gao, Qinglei
    BIOSCIENCE REPORTS, 2021, 41 (05)
  • [39] Transcriptomic profiles of response to neoadjuvant chemotherapy in patients with high-grade serous ovarian cancer
    Lee, Sanghoon
    Zhao, Li
    Fleming, Nicole D.
    Celestino, Joseph
    Hajek, Richard A.
    Morgan, Margaret B.
    Liu, Yan
    Westin, Shannon N.
    Jazaeri, Amir A.
    Liu, Jinsong
    Zhang, Jianhua
    Futreal, P. Andrew
    Sood, Anil K.
    CANCER RESEARCH, 2022, 82 (12)
  • [40] Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma
    Takaya, Hisamitsu
    Nakai, Hidekatsu
    Takamatsu, Shiro
    Mandai, Masaki
    Matsumura, Noriomi
    SCIENTIFIC REPORTS, 2020, 10 (01)